GRP
LGND icon

Global Retirement Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Global Retirement Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Buy
+1,369
New +$323K 0.01% 1110
2025
Q4 		$79K Buy
418
+182
+77% +$35K ﹤0.01% 2053
2025
Q3 		$41.8K Buy
236
+37
+19% +$5.5K ﹤0.01% 1999
2025
Q2 		$22.6K Buy
+199
New +$21.3K ﹤0.01% 2225
2024
Q4 		$4.5K Buy
42
+26
+163% +$2.94K ﹤0.01% 2729
2024
Q3 		$1.6K Buy
16
+8
+100% +$805 ﹤0.01% 3003
2024
Q2 		$674 Hold
8
– – ﹤0.01% 3246
2024
Q1 		$585 Hold
8
– – ﹤0.01% 3101
2023
Q4 		$569 Buy
+8
New +$472 ﹤0.01% 3049
2022
Q3 		– Sell
-6
Closed – – 2853
2022
Q2 		$0 Hold
6
– – ﹤0.01% 2798
2022
Q1 		$0 Buy
+6
New +$435 ﹤0.01% 2713
2018
Q4 		– Sell
-74
Closed -$13K – 1511
2018
Q3 		$13K Hold
74
– – ﹤0.01% 958
2018
Q2 		$10K Buy
+74
New +$8.26K ﹤0.01% 992
2018
Q1 		– Sell
-42
Closed -$4K – 1519
2017
Q4 		$4K Buy
+42
New +$3.64K ﹤0.01% 1167

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's LGND Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,369 shares worth $433K. The stake represents 0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in LGND as recently as Q4 2025.

Global Retirement Partners first reported a position in LGND in Q4 2017 and has held it in 14 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Global Retirement Partners held 1,369 shares of Ligand Pharmaceuticals worth $433K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1110 holding.
  • Global Retirement Partners first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 14 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.